Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:17:04.412Z.
Calculation as of: 2026-10-06T14:17:04.412Z.
Quote observation: 2026-10-06T14:15:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6a3e1feeb410069f07e4350e21f058018b4d4b1a35d97054c3a706da9d6a2f8d
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$85.18M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humacyte, Inc. (HUMA) | $84.59M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.18M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.04M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $84.29M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.97M | N/A | 3.67 | 3.67 | 3.67 |
| Cardiff Oncology, Inc. (CRDF)vs › | $86.32M | N/A | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $83.68M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 29.30 | 45.53 | 45.53 | 24.63 |
| Citius Oncology, Inc. (CTOR)vs › | $82.75M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $90.38M | 118.09 | 46.83 | 44.28 | 282.12 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$0.50
Forward EPS (Est.)
$-0.40
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2023-03-24 | 8.31 |
| 2023-03-23 | 8.83 |
| 2023-03-22 | 8.63 |
| 2023-03-21 | 8.29 |
| 2023-03-20 | 7.66 |
| 2023-03-17 | 8.40 |
| 2023-03-16 | 8.11 |
| 2023-03-15 | 8.14 |
| 2023-03-14 | 8.51 |
| 2023-03-13 | 7.60 |
| 2023-03-10 | 7.77 |
| 2023-03-09 | 8.14 |
| 2023-03-08 | 8.57 |
| 2023-03-07 | 9.17 |
| 2023-03-06 | 9.29 |
| 2023-03-03 | 8.97 |
| 2023-03-02 | 8.66 |
| 2023-03-01 | 8.71 |
| 2023-02-28 | 8.74 |
| 2023-02-27 | 8.57 |
| 2023-02-24 | 8.31 |
| 2023-02-23 | 8.69 |
| 2023-02-22 | 8.83 |
| 2023-02-21 | 8.69 |
| 2023-02-17 | 8.94 |
| 2023-02-16 | 8.77 |
| 2023-02-15 | 9.11 |
| 2023-02-14 | 8.77 |
| 2023-02-13 | 8.60 |
| 2023-02-10 | 8.23 |
| 2023-02-09 | 8.31 |
| 2023-02-08 | 9.14 |
| 2023-02-07 | 9.11 |
| 2023-02-06 | 8.94 |
| 2023-02-03 | 9.23 |
| 2023-02-02 | 8.80 |
| 2023-02-01 | 8.26 |
| 2023-01-31 | 7.51 |
| 2023-01-30 | 7.83 |
| 2023-01-27 | 7.94 |
| 2023-01-26 | 7.43 |
| 2023-01-25 | 7.17 |
| 2023-01-24 | 7.37 |
| 2023-01-23 | 7.51 |
| 2023-01-20 | 7.17 |
| 2023-01-19 | 7.11 |
| 2023-01-18 | 7.31 |
| 2023-01-17 | 7.40 |
| 2023-01-13 | 7.14 |
| 2023-01-12 | 7.11 |
| 2023-01-11 | 7.14 |
| 2023-01-10 | 7.11 |
| 2023-01-09 | 6.57 |
| 2023-01-06 | 6.43 |
| 2023-01-05 | 6.23 |
| 2023-01-04 | 6.11 |
| 2023-01-03 | 6.03 |
| 2022-12-30 | 6.03 |
| 2022-12-29 | 5.94 |
| 2022-12-28 | 5.77 |
| 2022-12-27 | 5.89 |
| 2022-12-23 | 6.57 |
| 2022-12-22 | 6.80 |
| 2022-12-21 | 6.03 |
| 2022-12-20 | 6.27 |
| 2022-12-19 | 6.31 |
| 2022-12-16 | 7.11 |
| 2022-12-15 | 7.43 |
| 2022-12-14 | 7.89 |
| 2022-12-13 | 8.06 |
| 2022-12-12 | 8.83 |
| 2022-12-09 | 8.57 |
| 2022-12-08 | 8.77 |
| 2022-12-07 | 8.49 |
| 2022-12-06 | 8.63 |
| 2022-12-05 | 9.26 |
| 2022-12-02 | 9.00 |
| 2022-12-01 | 8.97 |
| 2022-11-30 | 8.91 |
| 2022-11-29 | 8.77 |
| 2022-11-28 | 8.83 |
| 2022-11-25 | 9.06 |
| 2022-11-23 | 9.26 |
| 2022-11-22 | 9.34 |
| 2022-11-21 | 9.14 |
| 2022-11-18 | 8.37 |
| 2022-11-17 | 8.29 |
| 2022-11-16 | 8.20 |
| 2022-11-15 | 8.49 |
| 2022-11-14 | 9.00 |
| 2022-11-11 | 9.17 |
